SCHEMBL17814899

SCHEMBL17814899

OC[C@@H](O)[C@@H](c1ccccc1)c1ccc(F)cc1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTT P42858 3/20 0.42
KDM4E B2RXH2 1/20 0.42
EPHX1 P07099 1/20 0.41
SLC6A4 P31645 3/20 0.41
SLC6A2 P23975 1/20 0.41
CYP19A1 P11511 2/20 0.39
ALDH1A1 P00352 2/20 0.39
LMNA P02545 2/20 0.39
NPSR1 Q6W5P4 2/20 0.39
USP2 O75604 1/20 0.39
HPGD P15428 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
CNR2 P34972 1/20 0.39
SLC6A3 Q01959 2/20 0.38
MEN1 O00255 2/20 0.38
KMT2A Q03164 2/20 0.38
CYP1A2 P05177 1/20 0.38
CYP3A4 P08684 1/20 0.38
CYP2D6 P10635 1/20 0.38
CYP2C9 P11712 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5726832 0.92 AOC3 (0.41) HTTKDM4E
SCHEMBL301347 0.88 LMNA (0.44) KDM4ESLC6A4SLC6A2ALDH1A1LMNA
SCHEMBL246459 0.88 LMNA (0.44) KDM4ESLC6A4SLC6A2ALDH1A1LMNA
SCHEMBL19329845 0.83 SLC6A4 (0.46) EPHX1SLC6A4SLC6A2SLC6A3CYP3A4
SCHEMBL19346524 0.83 SLC6A4 (0.46) EPHX1SLC6A4SLC6A2SLC6A3CYP3A4
SCHEMBL17802378 0.81 TSHR (0.48) KDM4ESLC6A4SLC6A2LMNANPSR1
SCHEMBL17802370 0.81 HTR2A (0.50) EPHX1SLC6A4SLC6A2CYP19A1CNR2
SCHEMBL28028823 0.79 CACNA2D1 (0.44) HTTKDM4EEPHX1CYP19A1ALDH1A1
SCHEMBL11634860 0.79 HTR2A (0.48) SLC6A4SLC6A2ALDH1A1SLC6A3MEN1
SCHEMBL11636727 0.79 SLC6A2 (0.61) SLC6A4SLC6A2SLC6A3CYP3A4CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2016088138-A1 DIPHENYLOXIRANES, PROCESS FOR PREPARATION THEREOF, AND ITS USE IN AN ENANTIOSELECTIVE SYNTHESIS OF (+)-SERTRALINE COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) 2016-06-09 WO disclosed